Clinical Trial: Imaging Study of a TROP2 Binder in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07671092) titled 'Imaging Study of a TROP2 Binder in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC' on June 22.

Brief Summary: This imaging study aims to assess the feasibility, biodistribution, and dosimetry of a TROP2 binder in subjects with metastatic UC, HR+ and HER2- breast cancer, TNBC, or NSCLC.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Metastatic Urothelial Carcinoma Breast Cancer TNBC - Triple-Negative Breast Cancer Hormone Receptor Positive HER-2 Negative Breast Cancer NSCLC

Intervention: DIAGNOSTIC_TEST: RYZ211/212

Imaging Agent

Recruitment Status: NOT_YET_RECRUITING

Sponsor: RayzeBio, Inc. ...